ARCHIVES

VeriStrat Biomarker Test Predicts Treatment Outcomes In Phase III NSCLC Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

ASCO Conquer Cancer Foundation Awards $6 Million To Researchers

April 22, 2011

OMB Specifies One Year Only Funding for 200 grants Under Supplemental Appropriations Level of 6,200

September 6, 1985

Also Cancer incidence, mortality level off after declines in 1990s.

September 12, 2003

In Brief: Schmidt Confers With Califano, Fredrickson On NCI director; Senate Hearing March 15-16

February 18, 1977

Congress Urges CMS To Soften Proposal For Coverage Of ESAs in Oncology.

July 20, 2007

NCI, FDA Near Agreement On INDs; Young, Hoogstraten Clash On Rubidazone

January 14, 1977